Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $101.8700 (4.55%) ($93.7600 - $102.7000) on Mon. Sep. 16, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.84% (three month average) | RSI | 62 | Latest Price | $101.8700(4.55%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 3.4% a day on average for past five trading days. | Weekly Trend | LGND advances 2.9% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(60%) IWO(57%) XBI(55%) IWC(54%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -1.42% in a week (0% probabilities). VIXM(-33%) VXX(-20%) TLT(-15%) UUP(-4%) IGOV(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.42% (StdDev 2.84%) | Hourly BBV | 0 () | Intraday Trend | 5.2% | | | |
|
5 Day Moving Average | $95.77(6.37%) | 10 Day Moving Average | $92.03(10.69%) | 20 Day Moving Average | $92.62(9.99%) | To recent high | -15.2% | To recent low | 18.1% | Market Cap | $1.637b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |